Automated and Closed Cell Therapy Processing Systems Market Overview
FAQ's
Answer : According to Precedence Research, the global personalized medicine market size was worth at US$ 1.9 trillion in 2020 and is predicted to reach over US$ 5.7 trillion by 2030.
Answer : The global personalized medicine market size was estimated at US$ 1.9 trillion in 2020 and is expected to hit over US$ 5.7 trillion by 2030 with a registered CAGR of 11.6% from 2021 to 2030.
Answer : The factors driving the global personalized medicine market include an increase in the prevalence of various types of cancer, the affordability of personalized medicine therapy in cancer drugs and other disease indications.
Answer : The major players operating in the personalized medicine market are Illumina Inc., Precision Biologics, Danaher Corporation, GE Healthcare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., Biogen.
Answer : North America is the largest segment for personalized medicine market in terms of region. The dominance of North America in the global market can be attributed to an increasing number of regulatory approvals for customized medicine in the U.S., as well as increased acceptance of personalized medicine as diagnostic and therapeutic agents.
Get a Sample of this Report
Automated and Closed Cell Therapy Processing Systems Market
